Christopher Steer
ORCID: 0000-0002-7677-3339Also affiliated with UNSW Sydney, Albury Wodonga Health
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 5 papers. Top paper: “Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial”.
Howard I Scher, Shahneen Sandhu, Eleni Efstathiou, Primo N Lara, Evan Y Yu +90 more
Gábor Liposits, Sankalp Arora, Nina Rosa Neuendorff, Fábio Gomes, Jessica L. Krok‐Schoen +13 more
Joe Dennis, Jonathan P. Tyrer, Pei-Chen Peng, Simon G. Coetzee, Alberto Luiz P. Reyes +94 more
Laetitia Da Meda, Ines Pires da Silva, Wen Xu, Giovanni Grignani, Alexander M. Menzies +11 more
Christopher Steer, Leana Cabrera Chien, Jason Zittel, Andrew Artz, Selina Chow +5 more